Sign in

CIK 0001991792

  • Large accelerated filer

CG Oncology, Inc.

Sign in to watch
Ticker
CGON
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
371611499
Phone
+1 949-409-3700
Business address
3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
Open-market buys, last 90 days
$2,665,586
in 2 filings
Open-market sales, last 90 days
$227,045
in 3 filings, $227K under 10b5-1 plans

Net +$2,438,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-18 Kalofonos Isabel Chief Commercial Officer Purchase +3,751 $79.76 $299K 3,751
2026-10-15 Kalofonos Isabel Chief Commercial Officer Grant or award · Employee Stock Option (right to buy) +92,000 92,000

Page 1 of 1 · 2 trades